The insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk…
These are the stocks posting the largest moves in the premarket.…
The Eli Lilly and Co (NYSE:LLY) weightloss drug Tirzepatide, known as Zepbound and Mounjaro, has also been shown in two trials to help…
…
The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S.…
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN)…
Atossa Therapeutics Inc (NASDAQ:ATOS) and its research partner Quantum Leap Healthcare Collaborative announced the initiation of a new study evaluating...…
A staggering $1 trillion could be the annual cost to the US healthcare system if 40% of Americans with obesity begin…
…
A conversation TheStreet engaged in with Cuban about weight-loss drugs shifted from Novo Nordisks Ozempic to something new from Eli…
Analysts see weak trends for Trulicity, which led all Eli Lilly drugs in sales last year. But that wont keep…
The review examined several drugs from Novo Nordisk, including Wegovy, Ozempic, Rybelsus, and Saxenda, but did not include Eli Lillys…
CNBCs Jim Cramer reviewed Tuesdays market action, saying stocks that saw losses like Nvidia and Eli Lilly remain winners.…
These companies are close to launching new products that could supercharge revenue.…
…
Lillys stock has climbed in the triple digits over the past 12 months.…
Things are going exactly as planned for the biotech giant.…
Viking shares have soared recently on optimism about its program.…
Viking shares have soared recently on optimism about its program.…
One analyst following the company believes it could grow its revenue meaningfully this year.…
The rallys action still looks normal. Meta and Eli Lilly are holding key support.…
The rallys action still looks normal. Meta and Eli Lilly are holding key support.…
Here are Tuesdays biggest calls on Wall Street.…
Theres more to the Lilly story than just excellence in one treatment area.…
Theres more to the Lilly story than just excellence in one treatment area.…
Avalo (AVTX) surges on adding a new pipeline drug, which has its origins at Eli Lilly. Alongside the acquisition, it…
…
…
…
…
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Dont assume that because Berkshire is worth nearly $900 billion, its sure to get to $1 trillion first.…
Dont assume that because Berkshire is worth nearly $900 billion, its sure to get to $1 trillion first.…
Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.…
Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.…
Experts told Forbes incumbents Novo Nordisk and Eli Lilly are unlikely to cede much ground to rival weight loss drugs…
All three of these high-flying stocks could have more room to run.…
…
All three of these high-flying stocks could have more room to run.…
…
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the…
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the…
…
Eli Lilly just partnered with Amazon to help accelerate distribution of its various treatments.…
Eli Lilly , Novo Nordisk shares slide after CBO comments on obesity drugs…
A recent FDA announcement may have just put one company in the lead.…
Heres what could happen to Eli Lilly shares next.…
Free two-day shipping for Prime members and a direct-to-consumer sales model could accelerate sales of Eli Lillys Zepbound.…
Free two-day shipping for Prime members and a direct-to-consumer sales model could accelerate sales of Eli Lillys Zepbound.…
The drugmaker is caught up in an unexpected situation with regulators.…